Diagnostic Imaging Devices - Baltics

The Diagnostic Imaging Devices market market in the Baltics is anticipated to achieve a revenue of US$90.02m by 2024.
This projection indicates a steady annual growth rate (CAGR 2024-2029) of 5.45%.
Consequently, the market volume is predicted to reach US$117.30m by 2029.
When compared globally, it is noteworthy that the United States is expected to generate the highest revenue, amounting to US$11.93bn in 2024.
The Baltic countries are experiencing a growing demand for advanced diagnostic imaging devices to enhance their healthcare infrastructure.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Baltics is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies.

Customer preferences: Customers in the Baltics are increasingly demanding diagnostic imaging devices that offer high-quality imaging, faster scan times, and advanced features such as 3D imaging and image-guided interventions. This is driven by the need for accurate and timely diagnosis, as well as the desire to minimize patient discomfort and radiation exposure. Additionally, there is a growing preference for portable and compact imaging devices that can be easily transported and used in remote areas or smaller healthcare facilities.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in the Baltics is the adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, improved image quality, and the ability to easily store and share images electronically. This trend is driven by the increasing availability of digital imaging systems and the desire to streamline workflow and enhance diagnostic capabilities. Another trend is the integration of artificial intelligence (AI) in diagnostic imaging devices. AI algorithms can assist radiologists in analyzing medical images, improving accuracy and efficiency in diagnosis. This trend is driven by the growing interest in AI technologies and the potential to improve patient outcomes.

Local special circumstances: The Baltics, consisting of Estonia, Latvia, and Lithuania, have been investing in their healthcare infrastructure and technology, leading to increased demand for diagnostic imaging devices. These countries have been focusing on improving access to healthcare services, especially in rural areas, which has led to the establishment of new healthcare facilities and the need for advanced medical equipment. Additionally, the Baltics have a high prevalence of chronic diseases, such as cardiovascular diseases and cancer, which require frequent diagnostic imaging procedures. This further drives the demand for diagnostic imaging devices in the region.

Underlying macroeconomic factors: The growing Diagnostic Imaging Devices market in the Baltics is also influenced by underlying macroeconomic factors. The region has been experiencing economic growth, leading to increased healthcare spending and investment in medical technologies. Furthermore, the aging population in the Baltics is driving the demand for diagnostic imaging devices, as older individuals require more frequent medical imaging for age-related conditions. Additionally, the implementation of favorable government policies and reimbursement schemes for diagnostic imaging procedures has further stimulated market growth. In conclusion, the Diagnostic Imaging Devices market in the Baltics is developing due to increasing customer preferences for advanced medical imaging technologies, such as digital imaging and AI integration. The region's focus on improving healthcare infrastructure, high prevalence of chronic diseases, economic growth, and favorable government policies are also contributing to the market's growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.